@stockassassin.bsky.social
Reposted
$MDGL with promising data in compensated MASH fibrosis. Shows robust reduction in liver stiffness in open-label cohort of p3 trial. Registrational study ongoing for this patient group:
finance.yahoo.com/news/madriga...
$AKRO $ETNB
finance.yahoo.com/news/madriga...
$AKRO $ETNB
Madrigal Announces New Two-Year Data from the Compensated MASH Cirrhosis Arm of the MAESTRO-NAFLD-1 Trial Demonstrating Potential Benefit of Rezdiffra™ (resmetirom) in Patients with Compensated MASH C...
Patients achieved a mean 6.7 kPa reduction in liver stiffness as measured by vibration-controlled transient elastography (VCTE); this represents the largest reduction in liver stiffness reported in a ...
finance.yahoo.com
February 26, 2025 at 1:40 PM
$MDGL with promising data in compensated MASH fibrosis. Shows robust reduction in liver stiffness in open-label cohort of p3 trial. Registrational study ongoing for this patient group:
finance.yahoo.com/news/madriga...
$AKRO $ETNB
finance.yahoo.com/news/madriga...
$AKRO $ETNB